Haploidentical and matched unrelated donor allogeneic hematopoietic stem cell transplantation offer similar survival outcomes for acute leukemia.
Yin-Che WangCheng-Lun LaiTsung-Chih ChenJyh-Pyng GauChieh-Lin Jerry TengPublished in: Cancer reports (Hoboken, N.J.) (2024)
Haplo-HSCT may serve as an alternative to MUD-HSCT for the treatment of acute leukemia, offering similar survival outcomes.